Log In
    FLWS
    $2.83
    (-1.05%)
    ACCO
    $4.48
    (-1.97%)
    ARLP
    $26.4
    (0.99%)
    AUIAF
    $0.15
    (0%)
    AZZ
    $133.39
    (0.78%)
    BTBT
    $0.84
    (-0.7%)
    BTM
    $0.49
    (0%)
    CVKD
    $0.91
    (-5.21%)
    LCE:CA
    $0.23
    (7.14%)
    COCP
    $0.97
    (2.31%)
    CDRO
    $9.21
    (2.45%)
    CVGI
    $2.85
    (-1.04%)
    LODE
    $1.69
    (-1.17%)
    CMTL
    $1.32
    (6.45%)
    CNDT
    $1.7
    (-5.03%)
    CXW
    $29.87
    (-0.57%)
    CMLS
    $0.01
    (0%)
    DRCT
    $0.11
    (-46.86%)
    DLHC
    $3.61
    (-4.24%)
    SSP
    $2.07
    (-4.17%)
    ELDN
    $2.21
    (-3.91%)
    EVC
    $6.12
    (-1.77%)
    EDRY
    $44.97
    (2.44%)
    ESEA
    $66.17
    (-0.74%)
    FAT
    $0.16
    (0%)
    RAIL
    $4.4
    (4.02%)
    GDEV
    $9.75
    (1.88%)
    GOVX
    $0.19
    (-5.63%)
    GOCO
    $0.3
    (0%)
    GHM
    $68.27
    (3.28%)
    GLDD
    $17
    (0%)
    GYRE
    $6.07
    (3.76%)
    HMENF
    $1.61
    (0.92%)
    III
    $6.09
    (-1.46%)
    IPOOF
    $14.66
    (-0.88%)
    KELYA
    $16.58
    (-1.25%)
    KTOS
    $40.43
    (4.52%)
    LUCK
    $4.09
    (-2.15%)
    MAIA
    $1.11
    (-3.48%)
    MGROF
    $0.26
    (0%)
    NTRB
    $5.97
    (3.65%)
    OCGN
    $0.71
    (-4.23%)
    PERF
    $1.99
    (0%)
    QMCI
    $0.15
    (0%)
    RGP
    $2.66
    (-1.12%)
    SGA
    $8.2
    (0%)
    SHWZ
    $0
    (0%)
    SHIP
    $15.91
    (0.76%)
    SLQT
    $0.33
    (6.69%)
    SKYX
    $0.78
    (-6.59%)
    SNAL
    $2.41
    (7.59%)
    GEO
    $27.57
    (0.77%)
    ODP
    $28
    (0%)
    TNXP
    $5.3
    (2.51%)
    TSQ
    $3.26
    (-10.19%)
    TZOO
    $5.12
    (0.89%)
    UNCY
    $3.58
    (-7.97%)
    VVX
    $76.82
    (3.68%)
    VNCE
    $11.41
    (-4.44%)
    XELB
    $0.36
    (-0.03%)
    ZOMDF
    $0.08
    (2.75%)

    channelchek-in

    ‌
    10/26/2026

    Eledon Pharmaceuticals Reports Positive Kidney Transplant Trial Data as Tegoprubart Improves Quality of Life

    Eledon Pharmaceuticals reports positive Phase 2 BESTOW data showing tegoprubart improved quality of life and symptoms in kidney transplant patients.

    0
    3 min read
    • ‌
      Noble Capital Markets Research Morning Call

      Noble Capital Markets Research Morning Call

      Today’s Noble Capital Markets equity research reports, available with free Chann...

      58 min read

    • Anthropic Files for IPO as Revenue Surges to $16.3 Billion, Setting Stage for Historic AI Listing

      3 min read

    • Roche Signs $813 Million Zymeworks Cancer Drug Deal as Biotech Partnerships Accelerate

      3 min read
    View all

    News

    10/26/2026

    Release – Eledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus at American Society of Nephrology Kidney Week 2026 Annual Meeting

    7 min read
    ‌
    Release – Eledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus at American Society of Nephrology Kidney Week 2026 Annual Meeting
    10/26/2026

    Release – Star Equity Holdings Expands Energy Services Division with Machine Shop Acquisition in Vernal, Utah

    7 min read
    ‌
    Release – Star Equity Holdings Expands Energy Services Division with Machine Shop Acquisition in Vernal, Utah
    10/26/2026

    Eledon Pharmaceuticals Reports Positive Kidney Transplant Trial Data as Tegoprubart Improves Quality of Life

    3 min read
    ‌
    Eledon Pharmaceuticals Reports Positive Kidney Transplant Trial Data as Tegoprubart Improves Quality of Life
    10/26/2026

    Cosmos Health (COSM) – Building a Higher-Margin Healthcare Platform

    2 min read
    View all

    Research Reports

    Cosmos Health (COSM) – Building a Higher-Margin Healthcare PlatformCH(Seanergy Maritime (SHIP) – Raising Estimates, Fleet Growth AheadSM(Kodiak Copper Corp. (KDKCF) – Kodiak Advances MPD Metallurgy Ahead of Key 2027 CatalystsKCC(Unicycive Therapeutics (UNCY) – NDA Resubmission Accepted For FDA ReviewUT(
    View all

    Video Content

  • ‌
    Noble Roman's

    Noble Roman's

    Conference Presentation
    10/2/2026
  • ‌
    Collective Mining

    Collective Mining

    Conference Presentation
    10/2/2026
  • ‌
    Grid Metals

    Grid Metals

    Conference Presentation
    10/2/2026
  • ‌
    First Phosphate

    First Phosphate

    Conference Presentation
    10/2/2026
    • View all

    Movers

    Symbol
    Change
    HLF:CA
    77.45%
    CLRO
    52.92%
    EFOI
    28.67%
    EAF
    25.15%
    RENT
    22.61%
    View all
    Log In